| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |